Modular Medical director granted 250 stock options
Modular Medical, Inc. director Ellen O'Connor Vos received a grant of options to purchase 250 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Modular Medical, Inc. director Ellen O'Connor Vos received a grant of options to purchase 250 shares of common stock. The options have an exercise price of $4.55 per share, were fully vested and exercisable on the March 31, 2026 grant date, and expire on March 31, 2036. After this award, she beneficially owns 250 options of this class of derivative security.
Insider Trade Summary
Grant/Award: 250 shares
Grant/Award
1 txn
Insider
Vos Ellen O'Connor
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Option to purchase common stock | 250 | $0.00 | $0.00 |
Holdings After Transaction:
Option to purchase common stock — 250 contracts (Direct)
Footnotes (2)
- F1. The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.
- F2. In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."
Key Figures
Option grant size: 250 options
Exercise price: $4.55 per share
Expiration date: March 31, 2036
+2 more
5 metrics
Option grant size
250 options
Grant to director on March 31, 2026
Exercise price
$4.55 per share
Strike price of granted options
Expiration date
March 31, 2036
Option term end date
Beneficial ownership of this option class
250 options
Total following reported transaction
Transaction code
A (grant, award, or other acquisition)
SEC Form 4 transaction classification
Key Terms
Outside Director Compensation Plan, beneficial ownership, derivative security, exercise price
4 terms
Outside Director Compensation Plan financial
"The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan"
beneficial ownership financial
"column 9 reports only total beneficial ownership of the "class" of derivative security"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
derivative security financial
"total beneficial ownership of the "class" of derivative security reported in Column 1"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
exercise price financial
"Options that have different exercise prices or vesting terms are not considered"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Modular Medical (MODD) disclose in this Form 4 filing?
Modular Medical disclosed that director Ellen O'Connor Vos received options to buy 250 shares of common stock at $4.55 per share. The grant was fully vested on March 31, 2026, providing immediate exercisability as part of director compensation.
How many Modular Medical (MODD) options were granted to the director?
The director received options covering 250 shares of Modular Medical common stock. These options are a single award, fully vested on the grant date, and reflect the director’s total beneficial ownership of this specific class of option reported in the filing.
What is the exercise price and term of the MODD stock options granted?
The options have an exercise price of $4.55 per share and expire on March 31, 2036. This gives the director a long-dated right to purchase Modular Medical common stock at that fixed price if she chooses to exercise.
Was the Modular Medical (MODD) option grant part of a compensation plan?
Yes. The filing states the option was granted under Modular Medical’s Outside Director Compensation Plan. This indicates the award is a standard element of non-employee director compensation rather than an open-market transaction or discretionary trade by the director.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates